Stroke 120 action for faster treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a program called STROKE 120 that teaches communities in China how to recognize stroke symptoms and call an ambulance quickly. The goal is to see if it helps people get to the hospital within 4.5 hours, which can lead to better recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in one of 16 participating communities across 8 regions in China.
- Your community has a permanent population over 110,000, with at least 15% aged 60 or older.
- The hospital in your area treats over 90% of stroke patients and has a certified stroke center.
- Your community can put the STROKE 120 program into action.
- Your community is more than 20 kilometers away from another study community to avoid mixing of information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI-based health program can help prevent strokes in adults at high risk. If you qualify, you'll get support to manage your risk factors like blood pressure and diabetes.
This study tests if connecting smaller hospitals with stroke experts through telemedicine improves treatment for people having an acute ischemic stroke. It may help you get faster, better care if you live in a less populated area.
This trial tests a streamlined approach to quickly start endovascular therapy for people having a severe ischemic stroke caused by a blocked large or medium brain artery. It aims to reduce delays and improve recovery by coordinating the care team as soon as you arrive at the hospital.
This trial tests a new way for paramedics to quickly identify and prioritize stroke patients before they reach the hospital, which could help get you the right treatment faster.
This trial tests a telestroke triage process for people with suspected stroke. It aims to help emergency responders quickly connect you with stroke specialists, which could speed up treatment.
This trial tests whether BXOS110, an experimental injection, can help people recover better after an acute ischemic stroke (a stroke caused by a blood clot) when given within 3 hours of symptom onset. The study compares BXOS110 to a placebo to see if it reduces disability and improves recovery.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.